Biodefence vaccines (BioSante/USAMRIID)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameBiodefence vaccines (BioSante/USAMRIID)

Drug Alias NameStaphylococcus aureus vaccine - BioSante/USAMRIIDRicin vaccine - BioSante/USAMRIIDPlague vaccine - BioSante/USAMRIIDAnthrax vaccine - BioSante/USAMRIIDBiodefense vaccines - BioSante/USAMRIID

ClassificationVaccines > Application > Therapeutic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsPoisoningStaphylococcal InfectionsAnthrax

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesUS Army Medical Research Institute of Infectious Diseases Biosante

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesBiosante US Army Medical Research Institute of Infectious Diseases

Active IndicationsN/A

Inactive IndicationsPoisoningStaphylococcal InfectionsAnthrax

Other Information

ATC CodeN/A